154 related articles for article (PubMed ID: 12408717)
1. Syntheses and antitumor targeting G1 phase of the cell cycle of benzoyldihydroisoquinolines and related 1-substituted isoquinolines.
Bermejo A; Andreu I; Suvire F; Léonce S; Caignard DH; Renard P; Pierré A; Enriz RD; Cortes D; Cabedo N
J Med Chem; 2002 Nov; 45(23):5058-68. PubMed ID: 12408717
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of 1-phenyl-1,2,3,4-dihydroisoquinoline compounds as tubulin polymerization inhibitors.
Zheng CH; Chen J; Liu J; Zhou XT; Liu N; Shi D; Huang JJ; Lv JG; Zhu J; Zhou YJ
Arch Pharm (Weinheim); 2012 Jun; 345(6):454-62. PubMed ID: 22415658
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of 3-arylisoquinolines as antitumor agents.
Cho WJ; Park MJ; Chung BH; Lee CO
Bioorg Med Chem Lett; 1998 Jan; 8(1):41-6. PubMed ID: 9871625
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, structure and antitumor activity of new benz[d,e]isoquinoline-1,3-diones.
Braña MF; Castellano JM; Morán M; Emling F; Kluge M; Schlick E; Klebe G; Walker N
Arzneimittelforschung; 1995 Dec; 45(12):1311-8. PubMed ID: 8595091
[TBL] [Abstract][Full Text] [Related]
5. Topoisomerase I-mediated DNA cleavage as a guide to the development of antitumor agents derived from the marine alkaloid lamellarin D: triester derivatives incorporating amino acid residues.
Tardy C; Facompré M; Laine W; Baldeyrou B; García-Gravalos D; Francesch A; Mateo C; Pastor A; Jiménez JA; Manzanares I; Cuevas C; Bailly C
Bioorg Med Chem; 2004 Apr; 12(7):1697-712. PubMed ID: 15028262
[TBL] [Abstract][Full Text] [Related]
6. Antitumor agents. 3. Design, synthesis, and biological evaluation of new pyridoisoquinolindione and dihydrothienoquinolindione derivatives with potent cytotoxic activity.
Bolognese A; Correale G; Manfra M; Lavecchia A; Mazzoni O; Novellino E; La Colla P; Sanna G; Loddo R
J Med Chem; 2004 Feb; 47(4):849-58. PubMed ID: 14761187
[TBL] [Abstract][Full Text] [Related]
7. Novel multidrug resistance reversal agents.
Berger D; Citarella R; Dutia M; Greenberger L; Hallett W; Paul R; Powell D
J Med Chem; 1999 Jun; 42(12):2145-61. PubMed ID: 10377220
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationship studies of substituted isoquinoline analogs as antitumor agent.
Cheon SH; Park JS; Chung BH; Choi BG; Cho WJ; Choi SU; Lee CO
Arch Pharm Res; 1998 Apr; 21(2):193-7. PubMed ID: 9875430
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach.
Preti D; Romagnoli R; Rondanin R; Cacciari B; Hamel E; Balzarini J; Liekens S; Schols D; Estévez-Sarmiento F; Quintana J; Estévez F
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1225-1238. PubMed ID: 30141353
[TBL] [Abstract][Full Text] [Related]
10. 5,6-Dihydropyrrolo[2,1-a]isoquinolines as Alternative of New Drugs with Cytotoxic Activity.
Chávez-Santos RM; Reyes-Gutiérrez PE; Torres-Ochoa RO; Ramírez-Apan MT; Martínez R
Chem Pharm Bull (Tokyo); 2017 Oct; 65(10):973-981. PubMed ID: 28740026
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological properties of new benz[h]isoquinoline derivatives.
Janin YL; Carrez D; Riou JF; Bisagni E
Chem Pharm Bull (Tokyo); 1994 Apr; 42(4):892-5. PubMed ID: 8020124
[TBL] [Abstract][Full Text] [Related]
12. Mild C(sp
Romo-Pérez A; Miranda LD; Chávez-Blanco AD; Dueñas-González A; Camacho-Corona MDR; Acosta-Huerta A; García A
Eur J Med Chem; 2017 Sep; 138():1-12. PubMed ID: 28641156
[TBL] [Abstract][Full Text] [Related]
13. Analogues of amonafide and azonafide with novel ring systems.
Sami SM; Dorr RT; Alberts DS; Sólyom AM; Remers WA
J Med Chem; 2000 Aug; 43(16):3067-73. PubMed ID: 10956214
[TBL] [Abstract][Full Text] [Related]
14. Molecular docking studies, biological and toxicity evaluation of dihydroisoquinoline derivatives as potential anticancer agents.
Ziemska J; Guśpiel A; Jarosz J; Nasulewicz-Goldeman A; Wietrzyk J; Kawęcki R; Pypowski K; Jarończyk M; Solecka J
Bioorg Med Chem; 2016 Nov; 24(21):5302-5314. PubMed ID: 27624521
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of 5,6-dihydropyrrolo[2,1-a]isoquinolines featuring an intramolecular radical-oxidative cyclization of polysubstituted pyrroles, and evaluation of their cytotoxic activity.
Reyes-Gutiérrez PE; Camacho JR; Ramírez-Apan MT; Osornio YM; Martínez R
Org Biomol Chem; 2010 Oct; 8(19):4374-82. PubMed ID: 20672155
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and structure-activity relationships of new benzodioxinic lactones as potential anticancer drugs.
Romero M; Renard P; Caignard DH; Atassi G; Solans X; Constans P; Bailly C; Pujol MD
J Med Chem; 2007 Jan; 50(2):294-307. PubMed ID: 17228871
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological activity of ferrocenyl indeno[1,2-c]isoquinolines as topoisomerase II inhibitors.
Wambang N; Schifano-Faux N; Aillerie A; Baldeyrou B; Jacquet C; Bal-Mahieu C; Bousquet T; Pellegrini S; Ndifon PT; Meignan S; Goossens JF; Lansiaux A; Pélinski L
Bioorg Med Chem; 2016 Feb; 24(4):651-60. PubMed ID: 26740155
[TBL] [Abstract][Full Text] [Related]
18. Studies on the synthesis and in vitro antitumor activity of the isoquinolone derivatives.
Cheon SH; Lee JY; Chung BH; Choi BG; Cho WJ; Kim TS
Arch Pharm Res; 1999 Apr; 22(2):179-83. PubMed ID: 10230509
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of 1-(2-aminophenyl)isoquinolines and the biological activity of their cis-dichloro platinum(II) complexes.
von Nussbaum F; Miller B; Wild S; Hilger CS; Schumann S; Zorbas H; Beck W; Steglich W
J Med Chem; 1999 Sep; 42(18):3478-85. PubMed ID: 10479280
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of 3,4-diphenyl-1,2-dihydroisoquinolines as a new tamoxifen analogue.
Kihara M; Ikeuchi M; Nagao Y
Drug Des Discov; 1995 Jan; 12(3):259-71. PubMed ID: 7662832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
